About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)

NCT01825161·10 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AO Foundation, AO Spine

With

Orthopaedic Research Foundation

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Signed informed consent
Age between 18 and 75 years
Able to read and write English at an elementary level
Diagnosis of metastatic tumor of the spine

You may not be if

The primary cancer site is central nervous system or spine
History of substance abuse (recreational drugs, alcohol) within 12 months prior to screening
Is a prisoner
A disease or condition that would, in opinion of the investigator, preclude accurate evaluation (e.g. significant psychiatric disease)

The record

StatusCompleted

PhaseNo phase

Taking part454

StartedAug 2013

UpdatedSep 13, 2022

Conditions

Secondary Malignant Neoplasm of Vertebral Column

Where10

Kansas University Medical Center
Kansas City, Kansas, United States
Johns Hopkins University
Baltimore, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States

Clareo Health | The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)